Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Espie

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|March 11, 1998
Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?A Degeorges, A de Roquancourt, J M Extra, et al.
American Journal of Clinical Oncology|July 28, 2001
Gastric metastases from breast cancer: a retrospective series of 12 patientsL Zelek, P H Cottu, L Mignot, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1987
[Value of initial chemotherapy in the treatment of advanced cancers of the uterine cervix]P Payraudeau-Daoud, N Ciraru-Vigneron, G Bercau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group methodV Dieras, J M Extra, E Bellissant, et al.
Gynecologic Oncology|December 1, 1994
Dysgerminoma in a pure 45,X Turner syndrome: report of a case and review of the literatureJ Y Pierga, S Giacchetti, E Vilain, et al.
Bulletin Du Cancer|January 1, 1989
[Cancer of the breast: intensive treatment with bone marrow autografts]C Gisselbrecht, E Lepage, J M Extra, et al.
Bulletin Du Cancer|November 1, 1993
[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast]S Culine, J M Extra, M Espie, et al.
British Journal of Cancer|July 9, 2009
All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II TrialN Tubiana-Mathieu, P Bougnoux, D Becquart, et al.
British Journal of Cancer|June 1, 1994
p53 mutations and overexpression in locally advanced breast cancersA Faille, P De Cremoux, J M Extra, et al.
European Radiology|July 20, 2011
BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unitA-S Hamy, S Giacchetti, M Albiter, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|March 11, 1998
Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?A Degeorges, A de Roquancourt, J M Extra, et al.
American Journal of Clinical Oncology|July 28, 2001
Gastric metastases from breast cancer: a retrospective series of 12 patientsL Zelek, P H Cottu, L Mignot, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1987
[Value of initial chemotherapy in the treatment of advanced cancers of the uterine cervix]P Payraudeau-Daoud, N Ciraru-Vigneron, G Bercau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group methodV Dieras, J M Extra, E Bellissant, et al.
Gynecologic Oncology|December 1, 1994
Dysgerminoma in a pure 45,X Turner syndrome: report of a case and review of the literatureJ Y Pierga, S Giacchetti, E Vilain, et al.
Bulletin Du Cancer|January 1, 1989
[Cancer of the breast: intensive treatment with bone marrow autografts]C Gisselbrecht, E Lepage, J M Extra, et al.
Bulletin Du Cancer|November 1, 1993
[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast]S Culine, J M Extra, M Espie, et al.
British Journal of Cancer|July 9, 2009
All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II TrialN Tubiana-Mathieu, P Bougnoux, D Becquart, et al.
British Journal of Cancer|June 1, 1994
p53 mutations and overexpression in locally advanced breast cancersA Faille, P De Cremoux, J M Extra, et al.
European Radiology|July 20, 2011
BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unitA-S Hamy, S Giacchetti, M Albiter, et al.
Pageof 5